Display Settings:

Format

Send to:

Choose Destination
    Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4355-9.

    ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation.

    Source

    Department of Molecular Biology, Max-Planck-Institut für Biochemie, Martinsried, Germany.

    Abstract

    ERK6, a mitogen-activated protein (MAP) kinase-related serine/threonine kinase, is highly expressed in human skeletal muscle and appears to function as a signal transducer during differentiation of myoblasts to myotubes. In transfected 293 cells, activation of the 45-kDa enzyme results in tyrosine-phosphorylated 46- and 56-kDa forms, which phosphorylate myelin basic protein. Overexpression of wild-type ERK6 or the inactive mutant Y185F has no effect on fibroblast and myoblast proliferation, but it enhances or inhibits C2C12 cell differentiation to myotubes, respectively. Our findings suggest ERK6 to be a tissue-specific, differentiation signal-transducing factor that is connected to phosphotyrosine-mediated signaling pathways distinct from those activating other members of the MAP kinase family such as LRK1 and ERK2.

    PMID:
    8633070
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC39541
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk